SMU-CX1 is a specific TLR3 inhibitor (IC50: 0.11 µM) with IC50 ranging from 0.14-0.33 µM against multiple influenza A virus subtypes. SMU-CX1 inhibits the viral PB2 and NP proteins with an IC50 of 0.43 µM for SARS-CoV-2 activity. SMU-CX1 also inhibits inflammatory factors in host cells, including IFN-beta, IP-10, and CCL-5[1].
Molekulargewicht:
276.33
Reinheit:
99.9
CAS Nummer:
[10371-86-5]
Formel:
C18H16N2O
Target-Kategorie:
SARS-CoV,Toll-like Receptor (TLR)
Anwendungsbeschreibung:
MCE Product type: Natural Products
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
